The 144th Annual Meeting of the Pharmaceutical Society of Japan (Yokohama)

Mar 28 - Mar 31, 2024PACIFICO Yokohama

You can search for presentations in this event.

Search across all events.

The 144th Annual Meeting of the Pharmaceutical Society of Japan (Yokohama)

Mar 28 - Mar 31, 2024PACIFICO Yokohama

You can search for presentations in this event.

Search across all events.

Search Results(4,073)

[29-211-am01]FcγRIIIa binding affinity analysis of homogeneous asymmetric glycosylated IgG

○Methanee Hiranyakorn¹, Saeko Yanaka^2,3, Atsuji Kodama³, Shogo Iwamoto⁴, Asako Hoshinoo⁴, Koichi Kato^3,5,6, Shino Manabe^1,7(1. School of Pharmacy and Pharmaceutical Sciences, Hoshi University, 2. Faculty of Pharmaceutical Sciences, Kyushu University , 3. Exploratory Research Center on Life and Living Systems (ExCELLS), 4. Fushimi Pharmaceutical Co. Ltd., 5. Institute for Molecular Science (IMS) , 6. Graduate School of Pharmaceutical Sciences, Nagoya City University. , 7. Graduate School of Pharmaceutical Sciences & Faculty of Pharmaceutical Sciences, Tohoku University)

The 144th Annual Meeting of the Pharmaceutical Society of Japan (Yokohama)Fri. Mar 29, 2024

The 144th Annual Meeting of the Pharmaceutical Society of Japan (Yokohama)

The 144th Annual Meeting of the Pharmaceutical Society of Japan (Yokohama)

[29-211-am01]FcγRIIIa binding affinity analysis of homogeneous asymmetric glycosylated IgG

[29-211-am02]Diversity of chondroitin sulfate chains of proteoglycan from cartilage

[29-211-am03S]Preparation of photodegraded low molecular weight and oversulfated glycosaminoglycan

[29-211-am04]The effect of chitosan degradative products, glucosamine and chitosan oligosaccharide, on osteoclastic differentiation

[29-211-am05S]Development of O-GlcNAc proteomics method and comprehensive analysis of O-GlcNAcylated proteins during neuronal differentiation of Parkinson’s disease model cells

[29-211-am06]Intracellular PLIN2 protein levels regulation in a NEK2A dependent manner

[29-211-am07S]Analysis of the role of long-chain acyl-CoA synthetase (ACSL) 4 in drug-induced lung injury

[29-211-am08S]Role of Prostacyclin synthase in lipopolysaccharide-induced sepsis in vivo

[29-211-am09S]Inflammatory regulation by H-PGDS inhibitor in acute pancreatitis

[29-211-am10S]Analysis of mice lacking LPLAT10, an sn-1 lysophospholipid acyltransferase

[LS01]Market challenges and solutions for sample preparation

[29-211-pm01]Application of cyclodextrins targeting membrane lipids in assisted reproductive technologies

[29-211-pm02S]Changes in ceramide metabolism during DNA replication phase

[29-211-pm03]Uptake of oxidized low-density lipoprotein in the brown adipose tissue of mice via CD36

[29-211-pm04S]The effect of Reelin on the sphingomyelin in the neuronal plasma membrane

[29-211-pm05S]Discovery and functional analysis of a novel enzyme that phosphorylates ceramide under acidic conditions

[29-211-pm06S]Effect of 9-(E,Z)-Hydroxyoctadecadienoic acid (HODE) on lymphoma cell lines EL4 and E.G7-OVA

[29-211-pm07]Mechanism of mRNA degradation by CCR4-NOT complex

[29-211-pm08S]Effect of chemical modifications on the cytotoxicity of long-stranded DNA duplexes

[29-211-pm09]Modulation of Gapmer-ASO toxicity by incorporation of acyclic artificial nucleic acids

[29-211-pm10S]Cytotoxicity induced by cancer cell-selective heteroduplex nucleic acid construction

[29-211-pm11S]CD20 promotes BCR/TLR9 dependent cell proliferation by increasing surface IgM expression.

[29-211-pm12]The role of Traf5 in the IgA production by mouse mucosal tissues

[29-211-pm13]Functional analysis of CGRP in ulcerative colitis using genetically engineered mice

[29-211-pm14]Search for small molecule biomarkers to predict therapeutic efficacy of immune checkpoint inhibitors

[29-211-pm15]Exploration of biologically active modified nucleosides and analysis of cancer associated signaling mechanisms

[29-211-pm16S]The activation of nuclear receptor RXR facilitates the differentiation of intestinal macrophages through mitochondrial metabolism

[29-211-pm17S]HMG-CoA reductase inhibitor regulates Th2 differentiation

[29-211-pm18S]Analysis of GPR55 signaling in anti-tumor immunity

[29-211-pm19S]The CCL17-CCR4 axis is involved in Th17-mediated antitumor immunity in murine lung metastasis of 4T1 breast cancer cells

[29-211-pm20S]Eosinophil-mediated antitumor immunity against murine melanoma

[SL02]Pretargeting theranostics – delivery, imaging, and response

[S01-1]Challenges in Imaging and Therapy using light.

[S01-2]Development of novel ultrasound diagnostics and therapeutics by the combination of microbubbles and ultrasound

[S01-3]Development of theranostics probes targeting erythropoietin-producing hepatocellular A2 receptor expressed in cancer

[S01-4]Smart MRI Contrast Agents for Neuroscience and Cancer Research

[LS02]Preparation of spherical LNPs granule: From preparation of solvent-free LNPs to solidification via freeze-drying

[S11-1]Stable and minimum-size solubilization of membrane proteins with cocktails of phospholipid analogs

[S11-2]Synthetic strategy for membrane protein and its application

[S11-3]Development of lipid-peptide nanoparticles for membrane protein delivery

[S11-4]Oligosaccharide-based protein purification systems for enzyme discovery with novel catalytic activity

[S11-5]Development of residue-selective modification reactions

[S21-1]Probing Protein Complexes: Insights from Kinetics and Structural Analyses

[S21-2]NMR-based approaches for dynamic biological systems and applications for pharmaceutical sciences

[S21-3]Protein interaction analyses and drug discovery and development

[S21-4]R&D in the field of cryo-EM for pharmaceutical sciences at the Structural Biology Research Center

[S21-5]Cryo-electron microscopy-based drug discovery for infectious disease

[S02-1]The potential analysis of flavoring agents as novel functional foods

[S02-2]Search for food-derived ingredients with physiological effects

[S02-3]Anti-skin aging effects of kale-derived exosome-like nanoparticles